ShareHope Medicine Co., Ltd.

TPEX:8403 Stock Report

Market Cap: NT$3.9b

ShareHope Medicine Past Earnings Performance

Past criteria checks 2/6

ShareHope Medicine's earnings have been declining at an average annual rate of -5.1%, while the Healthcare industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 4.1% per year. ShareHope Medicine's return on equity is 2.3%, and it has net margins of 3.7%.

Key information

-5.1%

Earnings growth rate

-5.4%

EPS growth rate

Healthcare Industry Growth9.1%
Revenue growth rate4.1%
Return on equity2.3%
Net Margin3.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

ShareHope Medicine's (GTSM:8403) Returns On Capital Are Heading Higher

Mar 26
ShareHope Medicine's (GTSM:8403) Returns On Capital Are Heading Higher

Is ShareHope Medicine (GTSM:8403) Using Too Much Debt?

Feb 12
Is ShareHope Medicine (GTSM:8403) Using Too Much Debt?

ShareHope Medicine Co., Ltd. (GTSM:8403) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Jan 15
ShareHope Medicine Co., Ltd. (GTSM:8403) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

What We Make Of ShareHope Medicine's (GTSM:8403) Returns On Capital

Dec 16
What We Make Of ShareHope Medicine's (GTSM:8403) Returns On Capital

Investors Who Bought ShareHope Medicine (GTSM:8403) Shares A Year Ago Are Now Up 26%

Nov 18
Investors Who Bought ShareHope Medicine (GTSM:8403) Shares A Year Ago Are Now Up 26%

Revenue & Expenses Breakdown

How ShareHope Medicine makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:8403 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244,10015072812
31 Mar 243,95011270412
31 Dec 233,87312570012
30 Sep 233,7324164713
30 Jun 233,81814568716
31 Mar 233,99321570015
31 Dec 224,13729471616
30 Sep 224,27843374813
30 Jun 224,1623606957
31 Mar 223,9892966724
31 Dec 213,8502336490
30 Sep 213,9062097230
30 Jun 214,1453027300
31 Mar 214,1583397250
31 Dec 204,0992487100
30 Sep 203,7832026210
30 Jun 203,3881455810
31 Mar 203,2121365680
31 Dec 193,1241955550
30 Sep 193,1292405440
30 Jun 193,2141995460
31 Mar 193,1471534870
31 Dec 183,0571464440
30 Sep 182,916834030
30 Jun 182,732873430
31 Mar 182,6751153300
31 Dec 172,6171243190
30 Sep 172,5611322930
30 Jun 172,4681322920
31 Mar 172,3961202880
31 Dec 162,3301232850
30 Sep 162,2961152890
30 Jun 162,2431132880
31 Mar 162,2001212840
31 Dec 152,1352172820
30 Sep 152,0542232720
30 Jun 152,0132172600
31 Mar 151,9832072540
31 Dec 141,9691062470
30 Sep 141,9451212390
30 Jun 141,9121172390
31 Mar 141,8901052430
31 Dec 131,865892440

Quality Earnings: 8403 has a large one-off gain of NT$50.1M impacting its last 12 months of financial results to 30th June, 2024.

Growing Profit Margin: 8403's current net profit margins (3.7%) are lower than last year (3.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 8403's earnings have declined by 5.1% per year over the past 5 years.

Accelerating Growth: 8403's earnings growth over the past year (3.6%) exceeds its 5-year average (-5.1% per year).

Earnings vs Industry: 8403 earnings growth over the past year (3.6%) exceeded the Healthcare industry 3.6%.


Return on Equity

High ROE: 8403's Return on Equity (2.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies